{"data":[{"accessionNo":"0000906304-26-000181","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001448431","issuerName":"OptimizeRx Corp","ticker":"OPRX","cusip":"68401U204","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"ROYCE & ASSOCIATES LP","reportingCik":null,"personType":"IA","sharesOwned":1315057,"percentOfClass":6.98,"filedAt":"2026-10-21","canonicalUrl":"https://xoomar.com/markets/stocks/oprx"},{"accessionNo":"0000884589-26-000012","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001448431","issuerName":"OptimizeRx Corp","ticker":"OPRX","cusip":"68401U204","securityClass":"Common Stock","eventDate":"2026-07-07","reportingPerson":"KENNEDY CAPITAL MANAGEMENT LLC","reportingCik":null,"personType":"IA","sharesOwned":1248899,"percentOfClass":6.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/oprx"},{"accessionNo":"0002012383-26-002843","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001448431","issuerName":"OptimizeRx Corp","ticker":"OPRX","cusip":"68401U204","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":342250,"percentOfClass":1.8,"filedAt":"2026-07-29","canonicalUrl":"https://xoomar.com/markets/stocks/oprx"},{"accessionNo":"0000906304-26-000124","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001448431","issuerName":"OptimizeRx Corp","ticker":"OPRX","cusip":"68401U204","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"ROYCE & ASSOCIATES LP","reportingCik":null,"personType":"IA","sharesOwned":1089398,"percentOfClass":5.81,"filedAt":"2026-07-22","canonicalUrl":"https://xoomar.com/markets/stocks/oprx"},{"accessionNo":"0000102909-26-001930","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001448431","issuerName":"OptimizeRx Corp","ticker":"OPRX","cusip":"68401U204","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/oprx"},{"accessionNo":"0000102909-25-000249","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001448431","issuerName":"OptimizeRx Corp","ticker":"OPRX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":1059109,"percentOfClass":5.7,"filedAt":"2025-10-31","canonicalUrl":"https://xoomar.com/markets/stocks/oprx"}],"updatedAt":"2026-11-04T08:01:09.077Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/oprx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}